Free Trial

Augmedix Q1 2024 Earnings Report

Augmedix logo
$2.35 0.00 (0.00%)
As of 10/2/2024

Augmedix EPS Results

Actual EPS
-$0.12
Consensus EPS
-$0.12
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Augmedix Revenue Results

Actual Revenue
$13.47 million
Expected Revenue
$13.25 million
Beat/Miss
Beat by +$220.00 thousand
YoY Revenue Growth
N/A

Augmedix Announcement Details

Quarter
Q1 2024
Time
N/A

Augmedix Earnings Headlines

“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Augmedix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Augmedix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Augmedix and other key companies, straight to your email.

About Augmedix

Augmedix (OTCMKTS:AUGX) provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

View Augmedix Profile

More Earnings Resources from MarketBeat